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Diabetes mellitus is a heterogeneous group of disorders, in which hyperglycemia is a main feature. The objective was to evaluate
the involvement of RAGE, inﬂammatory cytokines, and metalloproteinases in spontaneous periodontitis triggered by diabetes
induction. Immunohistochemical procedures for MMP-2, MMP-9, TNF-α,I L - 1 β, IL-6, RANKL, and RAGE were performed in
rats after 1, 3, 6, 9, and 12 months of diabetes induction. Total DNA was extracted from paraﬃn-embedded tissues and evaluated
by Real-TimePCR for 16S total bacterial load and speciﬁc periodontopathogens. Our data did not demonstrate diﬀerences in
microbiological patterns between groups. In diabetic groups, an increase in RAGE-positive cells was detected at 6, 9, and 12
months, while TNF-alpha-stained cells were more prevalent at 6 and 12 months. In experimental groups, IL-β-positive cells were
increased after 12 months, IL-6 stained cells were increased at 9 and 12 months, and RANKL-positive cells at 9 months. Diabetes
resulted in widespread expression of RAGE, followed by expression of proinﬂammatory mediators, without major alterations
in oral microbial proﬁle. The pervasive expression of cytokines suggests that spontaneous periodontitis development may be
independent of microbial stimulation and may be triggered by diabetes-driven imbalance of homeostasis.
1.Introduction
Diabetes mellitus is a heterogeneous group of disorders
that aﬀect the metabolism of carbohydrates, lipids, and
proteins, in which hyperglycemia is a main feature. The
subsequent hyperglycemia has wide-ranging molecular and
cellular eﬀects, resulting in oxidative stress, upregulation
of proinﬂammatory responses, and vascular changes that
predispose individuals to the classic diabetes complications
of cardiovascular disease, nephropathy, retinopathy, neu-
ropathy, and atherosclerosis. Elevated blood glucose levels
have been associated with diabetic complications through-
out the acceleration of advanced glycation end products
(AGEs) formation [1, 2]. The interaction between AGEs and
their receptor RAGE generates reactive oxygen species and
activates inﬂammatory signaling cascades, demonstrating
the great inﬂuence of this interaction in the pathogenesis
of several chronic diseases such as Alzheimer’s disease,
nondiabetic nephropathy, and chronic kidney disease [3–5].
In addition, AGE-RAGE interaction is also associated with
diabetic complications [6, 7].
It also has been demonstrated that AGE-RAGE inter-
action results in increased levels of proinﬂammatory
mediators such as tumoral necrosis factor alpha (TNF-
alpha), interleukin-1beta (IL-1beta), interleukin-6 (IL-6),
and matrix metalloproteinases (MMPs) [8, 9]. In fact,2 Experimental Diabetes Research
previous studies [5, 10, 11] revealed that higher levels of
inﬂammatory mediators are related to diabetic complica-
tions such as nephropathy, neuropathy, retinopathy, and
cardiovascular diseases. Then, the central role of AGEs
and RAGE in maintaining perpetuated cell activation is
demonstratedinvarioustherapeuticattemptstoblockRAGE
or their ligands [12, 13].
Among the pathologies triggered or exacerbated by
diabetes, the eﬀect of chronic hyperglycemic in periodontal
environment has been characterized by an increase in peri-
odontitis prevalence and severity. In this way, periodontal
disease has been termed the sixth complication of diabetes
[14–16]. Several mechanisms have been proposed to explain
the interactions between diabetes and periodontal diseases.
These potential mechanisms are strikingly similar to those
associated with the established complications of chronic
diabetes, suggesting that increased severity of periodontal
disease in presence of diabetes was due to an exacer-
bated inﬂammatory response triggered by AGEs [17, 18].
In fact, clinical and experimental studies [15, 19]h a v e
been demonstrating an association between diabetes and
increased expression of inﬂammatory mediators, osteoclas-
togenic factors, and matrix metalloproteases. Some studies
[20, 21] also suggest that diabetes interfere in host defense
mechanisms such as chemotaxis, adherence, phagocytosis,
and apoptosis, contributing to tissue destruction.
These studies demonstrated that diabetes increases the
severity of periodontal disease previously induced by bac-
terial inoculation or by silk ligatures [22, 23]. However,
ap r e v i o u ss t u d y[ 24] demonstrated that a chronic hyper-
glycemic environment in periodontal tissue, even in absence
of external stimuli such as bacterial inoculation or silk
ligatures,resultsintheclearestablishmentandprogressionof
periodontal disease. In fact, previous reports suggested that
diabetes not only exacerbate the periodontitis severity but
also can trigger periodontal disease induction [25]. Interest-
ingly, it has been suggested that the inﬂammatory/immune
deregulation caused by diabetes could trigger periodontitis
development in response to the commensal subgingival
microﬂora [9, 16, 23]. However, the mechanisms involved
in the spontaneous onset of periodontitis after diabetes
induction remains unknown.
In this context, the purpose of this study was to
investigate the potential mechanisms involved in the spon-
taneous onset of diabetes-triggered periodontitis through
the quantitative and spatial evaluation of RAGE, TNF-alpha,
IL-1beta, IL-6, RANKL, MMP-2, MMP-9 immunostaining
patterns, and also the monitoring of oral microbiota load,
in periodontal tissue in rats after 1, 3, 6, 9, and 12 months of
diabetes induction.
2.MaterialandMethods
2.1. Induction of Diabetes and Collection of Samples. Adult
male Wistar rats, 10–12 weeks old, weighing approximately
250g, were submitted to diabetes induction by intravenous
administration of alloxan (Sigma Chemical Co., St Louis,
EUA) in a single dose of 42mg/kg of body weight into the
caudal vein. Only rats showing two successive determina-
t i o n so fb l o o dg l u c o s el e v e l s( 7a n d1 4d a y sa f t e ra l l o x a n
injection) greater than 250mg/dL were considered diabetic
and included in the experiment. The glucose levels during
the experiment were typically 400–450mg/dL in diabetic
rats, while serum glucose levels of control rats ranged from
90 to 130mg/dL. The animals were housed in metabolic
cages in groups of four per cage and fed a standard rat
chow and water ad libitum. Study protocol was approved by
the Experimental Committee of Bauru School of Dentistry,
S˜ ao Paulo State University (033/2007). Each diabetic and
control group was composed of 25 animals, subdivided
into 5 subgroups with 5 rats each, analyzed at 1, 3, 6, 9,
and 12 months after diabetes induction. On their respective
dates, the animals were sacriﬁced with overdose of sodium
pentobarbital (Crist´ alia Chemical Products-Itapira/SP) and
the hemimandibles were removed and ﬁxed in 10% formalin
solution for 7 days.
2.2. Histological and Immunohistochemical Analyses. The
hemimandibles were demineralized for 8 weeks in 4.13%
EDTA,washed,dehydrated,andembeddedinparaﬃn.Slides
of 5μm thick serial sections of the each hemimandible were
obtained (3 semi-serial sections for each protein/antibody
studied) and submitted to immunohistochemical proce-
dures. Immunohistochemistry was performed using the
Streptavidin-Biotin/HRP Complex method.
Paraﬃns e c t i o n s( 3s e m i - s e r i a ls e c t i o no fe a c ha n i m a l )
were deparaﬃnized with xylol, dehydrated in decreasing
alcohol solutions, and the endogenous peroxidase was
blocked with 3% hydrogen peroxide solution in phosphate-
buﬀered saline (PBS) for 30 minutes at room temperature.
For antigen retrieval, sections were treated with 0.5%
pepsin (IL-1beta, TNF-alpha, IL-6 and RAGE antibodies)
and 0.4mg/mL of proteinase K (RANKL antibody) for
20 minutes at room temperature. In MMP-2 and MMP-9
reactions,sectionsweresubmittedtosodiumcitrate(10mM;
pH 6.0) for 20 minutes at 95◦C. After antigen retrieval,
sections were incubated in 7% free-fat milk for 40 minutes
at room temperature.
A speciﬁc primary antibodies for MMP-9 (sc-6840-Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA) at 1:200
dilution;MMP-2(sc-58386-SantaCruzBiotechnology,Inc.),
at 1:100 dilution; RANKL (sc-7628-Santa Cruz Biotech-
nology, Inc.), at 1:50 dilution; RAGE (ab3611-Abcam Inc.,
Cambridge, USA), at 1:50 dilution; TNF-alpha (sc-1348-
Santa Cruz Biotechnology, Inc.), at 1:50 dilution; IL-1beta
(sc-7884-Santa Cruz Biotechnology, Inc.), at 1:50 dilution;
IL-6 (IL-6-Santa Cruz Biotechnology, Inc.), at 1:50 dilution
were applied and incubated for 2 hours at room temperature
in a humidiﬁed chamber.
After washing, the sections were incubated with biotin-
conjugated secondary antibody (sc-2774 and sc-2040-Santa
Cruz Biotechnology, Inc.) for 1h at room temperature
followed by streptavidin/peroxidase complex (Dakocytoma-
tion, Glostrup, Denmark) for 20 minutes at room tem-
perature. Immunoreactivity was developed using 3,30-
diaminobenzidine, for 5min (DakoCytomation, Glostrup,Experimental Diabetes Research 3
Denmark), counterstained with Harris’s hematoxylin and
mounted. All rinses were performed three times in 0.1%
PBS/Triton-X. Negative controls were performed replacing
the primaries antibodies for the same PBS/BSA solution.
Periodontal disease tissue was used as a positive control for
TNF-alpha, IL-1beta, IL-6, and RANKL [26]. Accordingly to
fabricant instruction, rat lung tissue exposed to tobacco was
used as positive control for MMP-2, MMP-9, and RAGE.
All histological sections were identiﬁed with a ran-
dom numerical sequence in order to codify experimental
periods and groups during the analysis procedures. A
single calibrated investigator analyzed the sections with a
binocular microscope (Olympus Optical Co., Tokyo, Japan).
Morphometrical measurements were obtained using a 100x
immersion objective and a Zeiss kpl 8x eyepiece containing
a Zeiss II integration grid (Carl Zeiss Jena GmbH, Jena,
Germany)with 10 parallellines and 100 points in a quadran-
gular area. The grid image was successively superimposed on
approximately 15 histological ﬁelds per histological section,
comprising all the periodontal area, from the junctional
epithelium to the root apex of mesial face of lower ﬁrst molar
mesial root. In each ﬁeld, immunostained cells are counted
andresultswerepresentedasnumberofimmunolabeledcells
per mm2 of tissue in each examined group.
2.3. DNA Extraction and Real-Time PCR Reactions. In order
to allow the quantiﬁcation of the bacteria, which potentially
invaded the host tissues, we performed the extraction of
bacterial DNA. Histological sections formalin-ﬁxed (3 semi-
serial section of each animal), paraﬃn-embedded tissue
sections comprising the teeth and surrounding structures
were submitted to DNA extraction with QIAamp DNA FFPE
TissueKit(QUIAGEN)followingmanufacturerinstructions.
Bacterial load (16S) was quantiﬁed by Real-Time-PCR
performed in a MiniOpticon system (BioRad, Hercules,
CA, USA), using SybrGreenMasterMix (Invitrogen), with
100nM speciﬁc primers and 5ng of DNA in each reaction,
as previously described [27].
2.4.StatisticalAnalyses. Atwo-wayANOVAwasemployedto
analyze data from all groups, followed by one-way ANOVA
and Tukey’s test to determine signiﬁcant diﬀerences within
the same group related to time. The signiﬁcance level was
always set at P<0.05, and all calculations were performed
usingGraphPadprogramPrism 3.0(GraphPadSoftwareInc,
EUA).
3. Results
Our immunohistochemical results did not show signiﬁcant
diﬀerences between control and experimental groups after
1 and 3 months of diabetes induction. However, diﬀerences
were detected after 6, 9, and 12 months regarding to RAGE,
TNF-alpha, IL-1beta, IL-6, and RANKL, as illustrated in
Figure 1.Theimmunoreactivecellsweredetectedindiﬀerent
regions of periodontal tissues with diﬀerent morphologies.
Considering that we did not observe a focal distribution
of immunostained cells, we performed a quantiﬁcation
comprising all regions of periodontium in order to quantify
the number of immunoreactive cells.
Regarding to RAGE, we initially detected increased
number of RAGE-positive cells in diabetic groups after 6
(P<0.001), 9 (P<0.01), and 12 (P<0.01) months when
compared to control group (Figure 2). Evaluating diﬀerent
periods of control group, we did not found any diﬀerences
in immunoreactivity patterns. Nevertheless, diabetic groups
revealed changes in the number of RAGE-positive cells
among periods of experimental design.
Our next step was to evaluate the number of positive
cells regarding to proinﬂammatory cytokines such as TNF-
alpha, IL-1beta, and IL-6 (Figure 3). Evaluating the number
of TNF-alpha-positive cells, we found a statistical signiﬁcant
increase in experimental groups after 6 (P<0.05) and 12
months (P<0.001) when compared to their respective
control groups (Figure 3). Diﬀerent time points of control
groups did not show any diﬀerences, while diabetic groups
revealed a trend of increase (P>0.05) after 3 months. This
diﬀerence became more pronounced at later periods, being
statistically signiﬁcant after 6 and 12 months.
Moreover, the number of IL-1beta-positive cells was
increased only after 12 months (P<0.001) in diabetic
group (Figure 3). In control groups, few immunoreactive
cells were detected in all periods; however, experimental
groups revealed a trend of increase (P>0.05) at 3, 6, and
9 months. In IL-6 experiments, we observed an increase in
the number of immunoreactive cells in diabetic groups at 9
(P<0.001) and 12 (P<0.01) months compared to control
groups (Figure 3).
Regarding to RANKL, diabetic groups presented the
same pattern as control groups in initial periods (1 and
3 months). However, a trend of increase (P>0.05) was
observed in next periods, being statistically signiﬁcant after
9 months of diabetes induction (P<0.001) (Figure 3).
In addition, we did not observe signiﬁcant statistical
diﬀerences between control and experimental groups in
MMP-2 and MMP-9 at any timepoints (Figure 4). We
observed few MMP-2-positive cells in initial periods with a
trend of increase (P>0.05) in control groups after 9 and
12 months. In experimental group, it was detected a slight
increase in the number of MMP-2-positive cells, followed by
a trend to reduction in the period of 12 months. We also
detected a trend of increase (P>0.05) in the number of
MMP-9-positive cells in diabetic group after 12 months of
diabetes induction.
These results are the mean value of 15 histological ﬁelds
per histological section, comprising all the periodontal area
from the gingival crest to the root apex. When the results
were individually analyzed by a subdivision of periodontal
area in cervical, medium, and apical regions (5 histological
ﬁelds in each region), no signiﬁcant diﬀerences were found
inthedistributionofimmunoreactivecells(datanotshown).
We also evaluated the overall microbial load in oral
cavity, and the results demonstrated that the levels of
16S bacterial DNA were similar in all the periods evalu-
ated in both diabetic and control groups (Figure 5). The
DNA samples extracted from periodontal tissue sections
were also investigated regarding the presence of classic4 Experimental Diabetes Research
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Figure 1: Increased number of immunoreactive cells after 9 months of diabetes induction in rats. Histological sections of periodontal tissues
were submitted to immunohistochemical analyses for RAGE (a), TNF-alpha (b), IL-1beta (c), IL-6 (d), and RANKL (e) after 9 months of
diabetes induction in rats. Observe the presence of immunoreactive cells in all regions of periodontium (cervical, medium, and apical
regions), being not limited to the gingival area.
periodontopathogens (Actinomyces actinomycetemcomitans,
Porphyromonas gingivalis, Prevotella nigrescens, Tannerella
forsythia, and Treponema denticola) but no positive samples
were observed in any period of both diabetic and control
groups (data not shown).
4. Discussion
It is well established that periodontal disease is more
severe and frequent in presence of diabetes [14–16], being
associated with higher levels of proinﬂammatory cytokines,
osteoclastogenic factors, and metalloproteases [19, 26, 28].
While the modulation of the established periodontal disease
bydiabetesseemstobeaconsensusinthescientiﬁcliterature,
the potential coinduction of periodontal disease by diabetes
recently demonstrated [14, 25] remains almost unknown.
In this context, the co-induction hypothesis proposed is
characterized by a “two-hit model,” where the “ﬁrst hit”
is supposed to be provided by the oral microﬂora. In this
way, the “second hit” is represented by the exacerbatedExperimental Diabetes Research 5
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Figure 2: Increased number of RAGE-positive cells in diabetic
groups. Histological sections of periodontal tissues were submitted
to immunohistochemical analyses for RAGE after 1, 3, 6, 9, and 12
months of diabetes induction. The results are presented as mean ±
SD of immunoreactive cells per mm2 in 3 semiserial section of each
animal, ∗P<0.05, one-way analysis of variance (ANOVA) followed
by Tukey’s test.
inﬂammatory response driven by systemic diseases such
diabetes [25].
In accordance with this coinduction hypothesis [25], our
previousresultsdemonstratedthatdiabetesinductiontrigger
alterations, which are typical of periodontal diseases even in
the absence of periodontitis induction [24]. However, in our
initial report, no attempts to characterize possible changes
in the overall oral microbial proﬁle as well to evaluate
potential mechanisms underlying spontaneous periodontitis
development were conducted. Then, the aim of this study
was to investigate the possible microbiological changes and
the spatial distribution and the number of immunostained
cells to RAGE, TNF-alpha, IL-1beta, IL-6, RANKL and
MMP-2, and MMP-9, in periodontal tissue after diabetes
induction.
Initially, we investigated the overall bacterial load in oral
cavity, represented by the 16S bacterial DNA levels, and our
results also did not show variations in periodontal bacterial
load, suggesting the absence of quantitative diﬀerences in
the bioﬁlm in both groups. Also, we investigated the pres-
ence of classical periodontopathogens such as Actinomyces
actinomycetemcomitans, Porphyromonas gingivalis, Prevotella
nigrescens, Tannerella forsythia, and Treponema denticola,
but no positive samples were found along the disease
developmentindiabeticgroupnorincontrolanimals.Inthis
way, our data suggest that the presence of diabetes did not
aﬀect qualitative and quantitative pattern of dental bioﬁlm.
Interestingly, previous studies showed that exacerbated
periodontal disease associated to diabetes is caused by clas-
sical periodontopathogens, but it is important to consider
that the aggravation of existing disease is distinct of the
coinduction situation, where classical periodontopathogens
were supposed to be absent in health conditions [29]. Then,
the establishment of periodontal disease seems to be a
result of an exacerbated response against a conventional
stimulus provided by the periodontopathogenic subgingival
microﬂora [25].
Thus, our next step was to investigate the possible eﬀects
of diabetes over host response throughout immunohisto-
chemical evaluations. Interestingly, we observed an increase
in the number of immunostained cells to RAGE after 6,
9, and 12 months of diabetes induction, conﬁrming the
involvement of these receptors. In agreement, it has been
found an increase in RAGE expression in the gingival tissues
of diabetic patients compared to nondiabetic patients with
periodontal disease [30, 31]. Likewise, diabetic mice showed
an increased AGEs deposition and RAGE expression in
the gingival tissues [32]. In addition, blockade of AGE-
RAGE interaction with soluble RAGE receptor in diabetic
mice decreased alveolar bone resorption and expression of
cytokines and metalloproteinases [13, 18]. Likewise, RAGE
was demonstrated to mediate osteoclasts formation and
activation with consequent bone resorption and decrease of
bone density, and to upregulate the expression of proinﬂam-
matory cytokines [33].
Accordingly, we observed an increased number of TNF-
alpha, IL-1beta, and IL-6-positive cells in diabetic groups.
Regarding to TNF-alpha, we found an increase in the
number of TNF-alpha-positive cells after 6 and 12 months
of diabetes induction. In accordance with our data, higher
serum levels of this cytokine have been detected in patients
with poorly controlled diabetes when compared to healthy
patients [34, 35]. Also, increased expression of TNF-alpha
was also observed in diabetic mice after oral inoculation of
Porphyromonas gingivalis [23]. In fact, macrophages from
diabetic patients had greater ability to produce TNF-alpha
when compared to macrophages from nondiabetic patients
[19]. It also has been demonstrated that LPS stimulation
resulted in a trend of increase in TNF-alpha, IL-1beta, and
IL-6 expression in vitro [36].
Regarding IL-1beta, we observed an increased number of
immunostaining cells after 12 months of diabetes induction.
Other studies also reported increased expression of IL-
1beta in diabetic patients with periodontal disease [19, 37].
Conversely, it has been described that diabetic patients with
periodontal disease presented decreased levels of IL-1 when
compared to non-diabetic patients [28], while other authors
did not found diﬀerences regarding to cytokines expression
indiabeticandnon-diabeticpatientswithperiodontitis[38].
It is possible that increased TNF-alpha and IL-1beta levels
aﬀect the expression of IL-6, considering that we detected an
increase in the number of immunostained cells to IL-6 after
9 and 12 months of diabetes induction. Considering that an
augment was observed in IL-6 expression in cultures of gin-
gival ﬁbroblasts stimulated with TNF-alpha and IL-1beta, it
hasbeensuggestedthatexacerbatedexpressionofTNF-alpha
and IL-1beta regulate IL-6 expression [39]. According to
our results, increased expression of IL-6 has been described
in diabetic patients with periodontitis [35]. Similarly, other
authors demonstrated a trend to increased IL-6 levels in
diabetic subjects with periodontal disease [37, 38].6 Experimental Diabetes Research
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Figure 3: Increased number of immunoreactive cells for TNF-alpha, IL-1beta, IL-6, and RANKL in diabetic groups. After 1, 3, 6, 9, and 12
months of diabetes induction, histological sections of periodontal tissues were submitted to immunohistochemical analyses for TNF-alpha,
IL-1beta, IL-6, and RANKL. The results are presented as mean ± SD of immunoreactive cells per mm2 in 3 semiserial section of each animal,
∗P<0.05, one-way analysis of variance (ANOVA) followed by Tukey’s test.
It is well established that the proinﬂammatory cytokines
above discussed present a great inﬂuence in osteoclastoge-
nesis and characteristically aﬀect RANKL expression [39].
Indeed, our data showed increased number of RANKL-
positive cells after 9 months of diabetes induction. Although
contradictory results have been demonstrated that diabetes
did not aﬀect RANKL expression [38], other authors showed
that diabetic mice presented decreased bone density accom-
panied by higher levels of RANKL, IL-1, and IL-6 [40].
Then, it has been described that increased expression of
RANKLaxissuggestingthatRANK/RANKL/OPGisinvolved
in the molecular basis of the association between diabetes
and periodontal disease [41].
In addition, other authors have evaluated the inﬂuence
of diabetes in MMPs expression, demonstrating higher levels
of MMP-8 and MMP-9 in periodontal tissue of diabetic
patients with periodontitis [42]. However, other authors did
not found diﬀerences in MMP-1 and MMP-8 expression in
periodontal tissue and gingival crevicular ﬂuid of diabetic
andnondiabeticpatients,bothwithperiodontaldisease[37].
Although our data did not show signiﬁcant diﬀerences in
MMP-2andMMP-9immunoreactivities,wedetectedatrend
of increase in the number of MMP-9-positive cells in rats
after 9 and 12 months of diabetes induction. Accordingly,
diﬀerences in MMP-2 levels in diabetic rats with ligature-
induced periodontal disease was not observed; however,Experimental Diabetes Research 7
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Figure 4: Absence of diﬀerences in the number of MMP-2 and MMP-9-positive cells between control and diabetic groups. After 1, 3, 6,
9, and 12 months of diabetes induction, histological sections of periodontal tissues were submitted to immunohistochemical analyses for
MMP-2(a) and MMP-9 (b). The results are presented as mean ± SD of immunoreactive cells per mm2 in 3 semiserial section of each animal,
∗P<0.05, one-way analysis of variance (ANOVA) followed by Tukey’s test.
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Figure 5: Variations in the number of immunoreactive cells is not
associated with bacterial load. Bacterial load (16S) in periodontal
tissues was quantiﬁed by Real-TimePCR, using SyberGreen system
and normalized by tissue weight. One-way analysis of variance
(ANOVA) followed by Tukey’s test.
higher levels of MMP-9 were detected [22]. Other authors
demonstrated that, even in the absence of periodontal
disease, MMP-8 and MMP-9 expression was increased in
periodontal tissue of diabetic rats, while no diﬀerences
were observed regarding to MMP-2 and MMP-3 between
control and diabetic groups [43]. In addition, it has been
demonstrated that the amount of glucose aﬀects the MMP-1
expression in vitro [44].
Based on these data, it is possible to suggest that
diabetes aﬀect expression of mediators related to establish-
ment and progression of periodontal disease. Although the
mechanisms remain poorly understood, the coinduction of
periodontitis by diabetes is supposed to be the result of the
RAGE/AGEs interaction, which results in the generation of a
proinﬂammatory environment [12, 13, 18, 31]. Accordingly,
the upregulation of RAGE immunoreactive cells number
precedes the increase of proinﬂammatory cytokines and
RANKL expression. Interestingly, these changes seem to
not be accompanied by a marked change in the overall
bacterial load in oral cavity. While this data do not support
the statement that the coinduction is independent of the
microbial stimuli, the pattern of immunostaining for all the
factorsinvestigateddemonstratethattheexpressionofRAGE
and cytokines is not limited to the gingival area, where the
periodontal bioﬁlm-stimulated responses characteristically
are localized. Therefore, it is possible to suggest that factors
other than the oral microﬂora could act as triggers, or the
“second hit”, in distinct areas of the periodontal tissues.
In this context, it is interesting to consider that RAGE
signalling results in an upregulation of TLR2 and TLR4
receptors, resulting in an MyD88-dependent signaling and
subsequent activation of NF-kappaB, increasing the expres-
sion of inﬂammatory cytokines such as IL-6, IL-1, and TNF-
alpha [45]. Classically, the pathogen-associated molecular
patterns (PAMPs) of commensal subgingival ﬂora are rec-
ognized as the typical ligands of TLRs in oral environment
[46]. However, the presence of high concentration of AGEs,
as a consequence of chronic hyperglycemia, may act as
an endogenous danger signal, related to damage-associated
molecular pattern (DAMPs), which can also trigger the
TLR/MyD88/NF-kappaB pathway. The identiﬁcation of this8 Experimental Diabetes Research
“danger signal” by atypical pattern-recognition receptors
such as RAGE seems to stimulate and exacerbate the
conventional response.
In this way, the initial inﬂammatory and immune
response could be sustained throughout the interaction
between the high concentrations of AGEs and atypical
pattern-recognition receptors such as RAGE. In this way,
DAMPs could not only activate the response but could also
inﬂuencethepatternofimmuneandinﬂammatoryresponse,
exacerbating these responses even in the absence of classic
PAMPs in areas of periodontal tissue distant from the gin-
g i v a lb i o ﬁ l m .T h ea b s e n c eo fd i ﬀerences could be explained
based on RAGE expression, which seems to be upregulated
in presence of chronic hyperglycemic environment.
Considering that higher levels of glycemia aﬀect all
periodontal regions, not only the regions in contact with
periodontopathogens, the absence of diﬀerences in the
distribution of immunoreactive cells could be explained
based on the central role of AGE-RAGE interaction, whose
c o u l db ed e t e c t e di na l lr e g i o n so fp e r i o d o n t a lt i s s u e s .I n
fact, this mechanism seems to be associated with arthritis
development, a chronic systemic disease related to altered
patterns of bone resorption, as observed in periodontitis
[47–49].
Taken together, diabetes seems to be associated with
host response dysfunction, which exacerbates the expres-
sion and/or activation of intracellular signaling molecules,
resulting in upregulation of inﬂammatory mediators. Our
results demonstrated that diabetes may trigger periodon-
tal disease induction throughout the dysregulation of
immune and inﬂammatory response against commensal
periodopathogenic microbiota. In fact, these biological
events may partially explain the increased severity of peri-
odontal disease and decreased ability to repair tissue in
presence of diabetes. However, further studies must be
carriedouttoimproveknowledgeontheinteractionbetween
diabetes and periodontal diseases, which may serve as a basis
for the development of more eﬀective strategies for preven-
tion and treatment of periodontitis in diabetic patients.
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